|
February 15, 2006
Angiotech partner announces French reimbursement for TAXUS(R) Liberté(TM) paclitaxel-eluting coronary stent system
February 7, 2006
AnorMED reports fiscal 2006 third quarter results and announces MOZOBIL(TM) Phase III recruitment reaches 50%
February 8, 2006
Aspreva Pharmaceuticals Reports 2005 Fourth Quarter and Year End Results
February 2, 2006
Aspreva Announces Preliminary Revenues for Fourth Quarter and Fiscal Year 2005
February 9, 2006
AstraZeneca Gives BC Healthcare System A Boost With $4.6 Million in Investments
February 3, 2006
CANTEST is one of Canada's 50 Best Managed Companies
February 13, 2006
Chemokine Therapeutics Supplies NCI With CTCE-9908 to Research Primary Effusion Lymphoma
February 6, 2006
Chemokine Therapeutics Receives Approval From Regulatory Authorities to Initiate Phase Ib/II Human Clinical Trial for its Anti Cancer Drug, CTCE-9908
February 9, 2006
Dr. Mohammad Azab Joins Chemokine Therapeutics' Board of Directors
February 2, 2006
Chromos Completes Acquisition of Targeted Molecules Corporation and Closes CDN. $6 Million Financing
February 13, 2006
Forbes Medi-Tech Announces Pharmavite Contract Renewal ~ Key Reducol™ Customer Continues Contract and Reports Strong Product Sales ~
February 6, 2006
Scripps Florida selects GenoLogics platform for lab and scientific data management for proteomics and systems biology research
February 2, 2006
GenoLogics Appoints Don Listwin to Board of Directors Former No. 2 Executive at Cisco Systems Joins Life Sciences Software Company
February 14, 2006
OncoGenex Appoints New CFO and Board Member
February 15, 2006
iCo Therapeutics Selects Isis Pharmaceuticals to Manufacture and Supply iCo 007
February 14, 2006
Inex Pharmaceuticals Receives Court Decision on Spin-out of Targeted Immunotherapy Assets
February 14, 2006
Inex Pharmaceuticals Appeal Hearing Completed
February 13, 2006
Inflazyme Pharmaceuticals Announces Financial Results for the Quarter Ended December 31, 2005
February 8, 2006
Perceptronix Received Medical Device Licenses for CLEARCYTE™ and CLEAR2C™ From Health Canada
February 2, 2006
Perceptronix Receives CE Mark for its First Product
February 14, 2006
The SFU UILO has two new technologies available for licensing: an X-ray Digital Imager (Medical) and Diagnostic and Drug Screening Technology for Invasive Aspergillosis |
